Sign Up Today and Learn More About Symbiont Stock
Invest in or calculate the value of your shares in Symbiont or other pre-IPO companies through EquityZen's platform.
Symbiont Stock (SYMB)
Symbiont has developed the market-leading platform for institutional applications of blockchain technology.
About Symbiont Stock
Founded
2015
Headquarters
New York, NY, US
Total Funding
15.4M
Industries
Financial Services, Other
Symbiont has developed the market-leading platform for institutional applications of blockchain technology. Symbiont smart contracts enable complex instruments to live their entire lifecycle on a truly decentralized, enterprise blockchain network with end-to-end privacy. Financial institutions and governments are working with Symbiont to develop new business lines, increase transparency, reduce risk, and save costs. Industry leaders such as Vanguard and the State of Delaware have chosen to partner with Symbiont. Headquartered in New York City, Symbiont is a financial technology company founded by a team of experts in capital markets and blockchain technology.
Symbiont Press Mentions
Stay in the know about the latest news on Symbiont
LM Funding Sells Symbiont's Blockchain Technology to Platonic Holdings Inc.
globenewswire • Dec 28, 2023
Symbiont’s blockchain tech up for grabs at floor price of $2.6 million
ledgerinsights • May 24, 2023
Symbiont.io Pursues Sale of Assets
businesswire • May 09, 2023
Bankruptcies of blockchain firms Marco Polo, Symbiont attract bidders
ledgerinsights • Mar 08, 2023
Blockchain startup Symbiont finds interim funding as part of Chapter 11
ledgerinsights • Jan 12, 2023
Investors in Symbiont
Discover investors in Symbiont stock and explore their portfolio companies
Symbiont Management
Leadership team at Symbiont
Founder
Evan Wagner
Founder & CEO
Mark Smith
Join now and verify your accreditation status to gain access to:
- Symbiont current valuation
- Symbiont stock price
- Available deals in Symbiont and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Symbiont Stock
How to invest in Symbiont stock?
Accredited investors can buy pre-IPO stock in companies like Symbiont through EquityZen funds. These investments are made available by existing Symbiont shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Symbiont stock?
Shareholders can sell their Symbiont stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
